SUPERNUS PHARMACEUTICALS INC. - COMMON STOCK
38.32
12-2月-25 09:33:47
15 分の遅延
株式
-0.33
-0.85%
本日の幅
38.31 - 38.60
ISIN
N/A
ソース
NASDAQ
-
Supernus Announces SPN-830 Apomorphine Infusion Device NDA Accepted for Review by FDA
19 8 2024 07:00:51 提供 Nasdaq GlobeNewswire
-
Supernus Announces Second Quarter 2024 Financial Results
06 8 2024 16:06:00 提供 Nasdaq GlobeNewswire
-
Supernus Resubmits NDA for SPN-830 Apomorphine Infusion Device
01 8 2024 16:30:11 提供 Nasdaq GlobeNewswire
-
23 7 2024 16:13:37 提供 Nasdaq GlobeNewswire
-
Supernus Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference
30 5 2024 16:25:33 提供 Nasdaq GlobeNewswire
-
23 5 2024 16:05:48 提供 Nasdaq GlobeNewswire
-
09 5 2024 16:05:39 提供 Nasdaq GlobeNewswire
-
Supernus Announces First Quarter 2024 Financial Results
08 5 2024 16:05:50 提供 Nasdaq GlobeNewswire
-
Busy Philipps Shines Spotlight on ADHD in Women and Shares her Qelbree Story
01 5 2024 08:00:32 提供 Nasdaq GlobeNewswire
-
24 4 2024 16:05:53 提供 Nasdaq GlobeNewswire
-
Supernus Provides Regulatory Update for SPN-830
08 4 2024 08:00:16 提供 Nasdaq GlobeNewswire
-
Supernus to Participate in Two Upcoming Investor Conferences
06 3 2024 16:30:50 提供 Nasdaq GlobeNewswire
-
Supernus to Participate in the TD Cowen 44th Annual Healthcare Conference
28 2 2024 16:30:04 提供 Nasdaq GlobeNewswire
-
Supernus Announces Fourth Quarter and Full Year 2023 Financial Results
27 2 2024 16:05:33 提供 Nasdaq GlobeNewswire
-
13 2 2024 16:05:20 提供 Nasdaq GlobeNewswire
-
Supernus Wins Infringement and Validity Case on Trokendi XR® against Torrent
05 2 2024 08:30:39 提供 Nasdaq GlobeNewswire
-
Supernus Announces Third Quarter 2023 Financial Results
08 11 2023 16:05:44 提供 Nasdaq GlobeNewswire
-
Supernus to Participate in the Jefferies London Healthcare Conference
07 11 2023 16:30:42 提供 Nasdaq GlobeNewswire
-
Supernus Announces SPN-830 Apomorphine Infusion Device NDA Accepted for Review by FDA
02 11 2023 07:00:05 提供 Nasdaq GlobeNewswire
-
25 10 2023 16:15:32 提供 Nasdaq GlobeNewswire